Argenx Acquires Forte Biosciences in Landmark $2.2 Billion Deal, Bolstering Immunology Pipeline with CD122-Targeting Antibody
admin Argenx, the Netherlands-based biopharmaceutical giant, announced on Monday, July 27, 2026, its definitive agreement to...
biotech
MapLight Therapeutics Shares Plummet by Two-Thirds After Phase 2 Schizophrenia Trial Results Spark Competitive Doubts Despite Positive Outcomes.
Brain drug developer MapLight Therapeutics witnessed a dramatic two-thirds erosion of its market value on...
Global Biotech Sector Rebounds with Surging Deals and Strategic Shifts in 2026: Insights from DIA China and BIO International
The global biotechnology sector is experiencing a significant resurgence of confidence in 2026, marked by...
Drs. Ken Murphy and Crystal Mackall on the ‘Long Game’ Behind Cancer Breakthroughs
At the highly anticipated 2026 AACR Annual Meeting, a beacon event in the global cancer...
The Unseen Foundation: Illuminating the Relentless Dedication Behind Cancer Breakthroughs
Long after the sun has set, casting the world into darkness, a solitary glow emanates...
Two Stage 4 Melanoma Survivors Share a Journey of Scientific Breakthrough, Enduring Hope, and the Profound Value of Ordinary Life
The rhythmic hum of daily life – the morning rush to school, the methodical push...
Biopharma Industry Roiled by Obesity Drug Marketing Dispute, Groundbreaking Oncology Advances, and AI Biotech Leadership Shift
The biopharmaceutical landscape witnessed a flurry of significant developments this week, from a heated legal...
A Promise Made, A Promise Kept: Meet the Inaugural CRI IGNITE Fellows
In a landmark announcement in October 2025, the Cancer Research Institute (CRI) unveiled the IGNITE...
Sanofi Halts Amlitelimab Development, Marking Significant Setback in Blockbuster Ambitions and Raising Questions on OX40L Target
Sanofi, the global pharmaceutical giant, has officially ceased further development and pursuit of regulatory approval...
The Cancer Research Institute’s Third Annual Bioinformatics Bootcamp Empowers Next Generation of Immunotherapy Researchers
From May 16 to 22, 2026, over 50 fellows and students converged at the prestigious...
